Ocular toxicity caused by paclitaxel in neonatal Sprague-Dawley rats

In Vivo

Volumn 23, Issue 4, 2009, Pages 555-560

  Kuwata, Maki ^a   Yoshizawa, Katsuhiko ^a   Matsumura, Miyo ^a   Takahashi, Kanji ^a   Tsubura, Airo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

Apoptosis; Cataract; Lens; Newborn; Paclitaxel; Rat; Retina; Retinal dysplasia

Indexed keywords

CASTOR OIL; PACLITAXEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CATARACT; CATARACTOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; EPITHELIUM CELL; EYE INJURY; EYE TOXICITY; FEMALE; HISTOPATHOLOGY; LENS EPITHELIUM; LENS FIBER; MALE; NEWBORN; NONHUMAN; RAT; ROSETTE FORMATION; SPRAGUE DAWLEY RAT; TOXICITY TESTING;

EID: 67650935919     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Li J, Tripathi RC and Tripathi BJ: Drug-induced ocular disorders. Drug Saf 31: 127-141, 2008.
2. Jobling AI and Augusteyn RC: What causes steroid cataracts? A review of steroid-induced posterior subcapsular cataracts. Clin Exp Optom 85: 61-75, 2002.
3. Jahnukainen K, Jahnukainen T, Salmi TT, Svechnikov K, Eksborg S and Söder O: Amifostine protects against early but not late toxic effects of doxorubicin in infant rats. Cancer Res 61: 6423-6427, 2001. (Pubitemid 32783247)
4. Bayer A, Evereklioglu C, Demirkaya E, Altun S, Karslioglu Y and Sobaci G: Doxorubicin-induced cataract formation in rats and the inhibitory effects of hazelnut, a natural antioxidant: a histopathological study. Med Sci Monit 11: BR300-304, 2005. (Pubitemid 41224396)
5. Weill JC, Leca G, Vincent A and Cotinat J: Bleomycin induces cataract formation in newborn rats in association with modifications of crystallin synthesis. Mol Biol Rep 4: 207-210, 1979.
6. Light AE: Additional observations on the effects of busulfan on cataract formation, duration of anesthesia, and reproduction in rats. Toxicol Appl Pharmacol 10: 459-466, 1967.
7. Lahav M, Albert DM and Wyand S: Clinical and histopathologic classification of retinal dysplasia. Am J Ophthalmol 75: 648-667, 1973.
8. Hirono I: Carcinogenicity and neurotoxicity of cycasin with sepcial reference to species differences. Fed Proc 31: 1493-1499, 1972.
9. Percy DH: Taratogenic effects of the pyrimidine analogues 5-iododeoxyuridine and cytosine arabinoside in late fetal mice and rats. Teratology 11: 103-117, 1975.
10. Percy DH and Danylchuk KD: Experimental retinal dysplasia due to cytosine arabinoside. Invest Ophthalmol Vis Sci 16: 353-364, 1977.
11. Eiden LE, Latker C and Zatz M: Retinal toxicity of methylazomethanol acetate is developmentally specific. Dev Brain Res 1: 425-428, 1981. (Pubitemid 11032971)
12. Nambu H, Taomoto M, Ogura E and Tsubura A: Time-specific action of N-methyl-N-nitrosourea in the occurrence of retinal dysplasia and retinal degeneration in neonatal mice. Pathol Int 48: 199-205, 1998. (Pubitemid 28204792)
13. Nambu H, Yoshizawa K, Yang J, Yamamoto D and Tsubura A: Age-specific and dose-dependent retinal dysplasia and degeneration induced by a single intraperitoneal administration of N-methyl-N-nitrosourea to rats. J Toxicol Pathol 11: 127-131, 1998.
14. Yang J, Yoshizawa K, Shikata N, Kiyozuka Y, Senzaki H and Tsubura A: Retinal damage induced by cisplatin in neonatal rats and mice. Curr Eye Res 20: 441-446, 2000.
15. Rowinsky EK and Donehower RC: Paclitaxel (Taxol). N Engl J Med 332: 1004-1014, 1995.
16. Daniels SA, Coonley KG and Yoshizumi MO: Taxol treatment of experimental proliferative vitreoretinopathy. Graefes Arch Clin Exp Ophthalmol 228: 513-516, 1990. (Pubitemid 20362509)
17. Izbicka E, Campos D, Marty J, Carrizales G, Mangold G and Tolcher A: Molecular determinants of differential sensitivity to docetaxel and paclitaxel in human pediatric cancer models. Anticancer Res 26: 1983-1988, 2006.
18. Suárez F, Jockovich ME, Hernandez E, Feuer W, Parel JM and Murray TG: Paclitaxel in the treatment of retinal tumors of LH beta-Tag murine transgenic model of retinoblastoma. Invest Ophthalmol Vis Sci 48: 3437-3440, 2007. (Pubitemid 351261076)
19. Horton TM, Ames MM, Reid JM, Krailo MD, Pendergrass T, Mosher R, Reaman GH and Seibel NL: A Phase 1 and pharmacokinetic clinical trial of paclitaxel for the treatment of refractory leukemia in children: a Children's Oncology Group study. Pediatr Blood Cancer 50: 788-792, 2008. (Pubitemid 351354786)
20. Geller JI, Wall D, Perentesis J, Blaney SM, Bernstein M. Phase I study of paclitaxel with standard dose ifosfamide in children with refractory solid tumors: a Pediatric Oncology Group study (POG 9376). Pediatr Blood Cancer 52: 346-350, 2009.
21. Modares Gilani M, Karimi Zarchi M, Behtash N, Ghaemmaghami F, Mousavi AS and Behnamfar F: Preservation of pregnancy in a patient with advanced ovarian cancer at 20 weeks of gestation: case report and literature review. Int J Gynecol Cancer 17: 1140-1143, 2007. (Pubitemid 47414829)
22. Hofstra LS, de Vries EG and Willemse PH: Ophthalmic toxicity following paclitaxel infusion. Ann Oncol 8: 1053, 1997.
23. Joshi MM and Garretson BR: Paclitaxel maculopathy. Arch Ophthalmol 125: 709-710, 2007.
24. Kim SC, Kim DW, Shim YH, Bang JS, Oh HS, Wan Kim S and Seo MH: In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release 72: 191-202, 2001.
25. Scialli AR, DeSesso JM and Goeringer GC: Taxol and embryonic development in the chick. Teratog Carcinog Mutagen 14: 23-30, 1994.
26. Rubin LF: Toxicologic update of dimethyl sulfoxide. Ann N Y Acad Sci 411: 6-10, 1983.
27. Tsubura A, Yoshizawa K, Miki K, Oishi Y and Kiuchi K: Animal models for human cataract with special emphasis on N-methyl-N-nitrosourea-induced rat cataractogenesis. Anim Eye Res 24: 1-8, 2005.
28. Yoshizawa K, Oishi Y, Nambu H, Yamamoto D, Yang J, Senzaki H, Miki H and Tsubura A: Cataractogenesis in neonatal Sprague-Dawley rats by N-methyl-N-nitrosourea. Toxicol Pathol 28: 555-564, 2000.
29. Mikuni I, Fujiwara T and Obazawa H: Microtubules in experimental cataracts: disappearance of microtubules of epithelial cells and lens fibers in colchicine-induced cataracts. Tokai J Exp Clin Med 6: 297-303, 1981. (Pubitemid 12249576)
30. Smith SB and Yielding KL: Retinal degeneration in the mouse. A model induced transplacentally by methylnitrosourea. Exp Eye Res 43: 791-801, 1986.
31. Silverstein AM, Osburn BI and Prendergast RA: The pathogenesis of retinal dysplasia. Am J Ophthalmol 72: 13-21, 1971.
32. Weidman TA and Kuwabara T: Postnatal development of the rat retina. Arch Ophthalmol 79: 470-484, 1968.